Clinical Trials Browser

Phase 3 × tebentafusp × 90 days × Clear all

NCT06246149 2026-03-04

ATOM

Phase 3 Recruiting

Uveal Melanoma

NCT05549297 2026-02-25

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Phase 3 Recruiting

Melanoma, Nevus, Blue